君实生物(688180.SH)：第三季度净亏损1.83亿元

Core Viewpoint - Junshi Biosciences (688180.SH) reported a significant increase in revenue for Q3 2025, but still faced a net loss attributed to shareholders [1] Financial Performance - The company's operating revenue reached 637 million yuan, representing a year-on-year increase of 31.40% [1] - The net profit attributable to shareholders was -183 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -191 million yuan [1]